© 1988 Oxford University Press
research-article |
Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline
Biochemistry Division, National Cancer Center Research Institute 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104, Japan
Carcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx), which is a potent mutagen first isolated from fried beef and widely present in various cooked foods, was tested in both sexes of F344 rats. Rats were continuously given a diet containing 0.04% MeIQx or basal diet and the experiment was finished on day 429. In experimental animals, the incidence of liver, Zymbal gland, clitoral gland and skin tumors was significantly higher than in control animals. The incidence of liver tumors was 100% in males and 53% in females; most liver tumors of males were hepatocellular carcinomas and all liver tumors of females were neoplastic nodules. The incidence of Zymbal gland tumors was 75% in males and 53% in females. Clitoral gland tumors were induced in 63% and skin tumors were observed in 35% of males and 5% of females. Most of these three types of tumors were diagnosed as squamous cell carcinoma. In the control rats, liver, Zymbal gland, clitoral gland and skin tumors were not observed in either sex.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. J. Metry, J. R. Neale, J. Bendaly, N. B. Smith, W. M. Pierce Jr., and D. W. Hein Effect of N-Acetyltransferase 2 Polymorphism on Tumor Target Tissue DNA Adduct Levels in Rapid and Slow Acetylator Congenic Rats Administered 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline Drug Metab. Dispos., November 1, 2009; 37(11): 2123 - 2126. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sinha, Y. Park, B. I. Graubard, M. F. Leitzmann, A. Hollenbeck, A. Schatzkin, and A. J. Cross Meat and Meat-related Compounds and Risk of Prostate Cancer in a Large Prospective Cohort Study in the United States Am. J. Epidemiol., November 1, 2009; 170(9): 1165 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Murai, S. Mori, J. S. Kang, K. Morimura, H. Wanibuchi, Y. Totsuka, and S. Fukushima Evidence of a Threshold-Effect for 2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline Liver Carcinogenicity in F344/DuCrj Rats Toxicol Pathol, April 1, 2008; 36(3): 472 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bendaly, S. Zhao, J. R. Neale, K. J. Metry, M. A. Doll, J. C. States, W. M. Pierce Jr., and D. W. Hein 2-Amino-3,8-Dimethylimidazo-[4,5-f]Quinoxaline-Induced DNA Adduct Formation and Mutagenesis in DNA Repair-Deficient Chinese Hamster Ovary Cells Expressing Human Cytochrome P4501A1 and Rapid or Slow Acetylator N-Acetyltransferase 2 Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1503 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nishikawa-Ogawa, H. Wanibuchi, K. Morimura, A. Kinoshita, T. Nishikawa, S. Hayashi, Y. Yano, and S. Fukushima N-acetylcysteine and S-methylcysteine inhibit MeIQx rat hepatocarcinogenesis in the post-initiation stage Carcinogenesis, May 1, 2006; 27(5): 982 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wanibuchi, M. Wei, M. R. Karim, K. Morimura, K. Doi, A. Kinoshita, and S. Fukushima Existence of No Hepatocarcinogenic Effect Levels of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline with or without Coadministration with Ethanol Toxicol Pathol, April 1, 2006; 34(3): 232 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nishikawa, T. Imazawa, Y. Kuroiwa, Y. Kitamura, K. Kanki, Y. Ishii, T. Umemura, and M. Hirose Induction of Colon Tumors in C57BL/6J Mice Fed MeIQx, IQ, or PhIP Followed by Dextran Sulfate Sodium Treatment Toxicol. Sci., April 1, 2005; 84(2): 243 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hoshi, K. Morimura, H. Wanibuchi, M. Wei, E. Okochi, T. Ushijima, K. Takaoka, and S. Fukushima No-Observed Effect Levels for Carcinogenicity and for in vivo Mutagenicity of a Genotoxic Carcinogen Toxicol. Sci., October 1, 2004; 81(2): 273 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawamori, Y. Totsuka, N. Uchiya, T. Kitamura, H. Shibata, T. Sugimura, and K. Wakabayashi Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats Carcinogenesis, October 1, 2004; 25(10): 1967 - 1672. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Masumura, Y. Totsuka, K. Wakabayashi, and T. Nohmi Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse Carcinogenesis, December 1, 2003; 24(12): 1985 - 1993. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsuda, S. Fukushima, H. Wanibuchi, K. Morimura, D. Nakae, K. Imaida, M. Tatematsu, M. Hirose, K. Wakabayashi, and M. A. Moore Value of GST-P Positive Preneoplastic Hepatic Foci in Dose-Response Studies of Hepatocarcinogenesis: Evidence for Practical Thresholds with Both Genotoxic and Nongenotoxic Carcinogens. A Review of Recent Work Toxicol Pathol, January 1, 2003; 31(1): 80 - 86. [Abstract] [PDF] |
||||
![]() |
S. Murray, B. G. Lake, S. Gray, A. J. Edwards, C. Springall, E. A. Bowey, G. Williamson, A. R. Boobis, and N. J. Gooderham Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man Carcinogenesis, September 1, 2001; 22(9): 1413 - 1420. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Gooderham, S. Murray, A. M. Lynch, M. Yadollahi-Farsani, K. Zhao, A. R. Boobis, and D. S. Davies Food-Derived Heterocyclic Amine Mutagens: Variable Metabolism and Significance to Humans Drug Metab. Dispos., April 1, 2001; 29(4): 529 - 534. [Abstract] [Full Text] |
||||
![]() |
M-W Yu, C-I Pai, S-Y Yang, T-J Hsiao, H-C Chang, S-M Lin, Y-F Liaw, P-J Chen, and C-J Chen Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk Gut, November 1, 2000; 47(5): 703 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A.J. Schut and E. G. Snyderwine DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis Carcinogenesis, March 1, 1999; 20(3): 353 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Han, Y. Kato, H. Kusuhara, H. Suzuki, M. Shimoda, E. Kokue, and Y. Sugiyama Kinetic profile of overall elimination of 5-methyltetrahydropteroylglutamate in rats Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E580 - E587. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Dingley, S. P. H. T. Freeman, D. O. Nelson, R. C. Garner, and K. W. Turteltaub Covalent Binding of 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline to Albumin and Hemoglobin at Environmentally Relevant Doses. Comparison of Human Subjects and F344 Rats Drug Metab. Dispos., August 1, 1998; 26(8): 825 - 828. [Abstract] [Full Text] |
||||
![]() |
M. S. Solomon, P.-M. L. Morgenthaler, R. J. Turesky, and J. M. Essigmann Mutational and DNA Binding Specificity of the Carcinogen 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline J. Biol. Chem., August 2, 1996; 271(31): 18368 - 18374. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.J. Gooderham, A. Soames, J.C. Rice, A.R. Boobis, and D.S. Davies Distribution and Elimination of [2-14C]Amino-3, 8-Dimethylimidazo [4, 5-f] quinoxaline in Mice. Analysis by Whole Animal Autoradiography Human and Experimental Toxicology, January 1, 1991; 10(5): 337 - 345. [Abstract] [PDF] |
||||









